Nephros (NEPH) Interest & Investment Income (2010 - 2026)
Nephros (NEPH) recorded quarterly Interest & Investment Income of $32000.0 in Q1 2026, down 40.74% quarter-over-quarter from $54000.0 in Q4 2025, and up 146.15% on a YoY basis from $13000.0 in Q1 2025.
Nephros (NEPH) Interest & Investment Income (2010 - 2026) Analysis & Trends
Nephros' Interest & Investment Income history runs 13 years deep, the most recent figure standing at $32000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 146.15% year-over-year to $32000.0; the TTM figure through Mar 2026 stood at $158000.0 (up 92.68% YoY), while the FY2025 annual figure was $139000.0, up 47.87% from the prior year.
- Interest & Investment Income was $32000.0 for Q1 2026 at Nephros, down from $54000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $54000.0 in Q4 2025 to a low of $1000.0 in Q2 2022.
- Historically, Interest & Investment Income has averaged $20176.5 across 5 years, with a median of $20000.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income slumped 66.67% in 2022, then soared 1200.0% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $7000.0 in 2022, then surged by 300.0% to $28000.0 in 2023, then changed by 0.0% to $28000.0 in 2024, then soared by 92.86% to $54000.0 in 2025, then sank by 40.74% to $32000.0 in 2026.
- The last three Interest & Investment Income figures came in at $32000.0 (Q1 2026), $54000.0 (Q4 2025), and $41000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -66.00 Mn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | 32,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 54,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Sep 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 3,000.00 |